Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 1478 350008

Carnitine and lipid profile in pemphigus vulgaris patients: A double-blind randomized controlled trial


20th World Dermatology and Aesthetic Congress

July 23-24, 2018 Kuala Lumpur, Malaysia

Elham Yaghubi

Tehran University of Medical Sciences, Iran

Posters & Accepted Abstracts: J Clin Exp Dermatol Res

Abstract :

Background: Pemphigus Vulgaris (PV) is a rare, autoimmune bullous disease of the skin and mucous membranes. Corticosteroids are usually the main core treatment for control of PV, which could result in complicating disorders. Objective: This study aimed to determine the lipid-lowering effects of L-carnitine supplementation in PV patients. Methods: In this randomized, double-blind, placebo-controlled clinical trial, 52 patients with PV were divided randomly into two groups to receive 2 g L-carnitine (n=26) or placebo (n=26) for 8 weeks. Serum levels of L-Carnitine (LC) and lipid profiles were evaluated at the beginning and end of the study. Results: Only 47 participants [LC group (n=24) and placebo group (n=23)] completed the trial. L-carnitine intake considerably decreased serum levels of triglycerides (TG, P=0.02), total cholesterol (TC, P<0.001), low density lipoprotein-cholesterol (LDL-C, P=0.01) and very low density lipoprotein-cholesterol (VLDL-C, P=0.02). In addition, there was a significant increase in serum carnitine (P<0.001) and non-significant change in high density lipoprotein-cholesterol (HDL-C, P=0.06) in comparison with the placebo. Within-group comparisons also demonstrated that serum TG (P=0.001), TC (0.001), LDL-C (P=0.003) and VLDL-C (P=0.001) significantly declined and the mean concentration of carnitine (P<0.001) and HDL-C (P<0.001) significantly increased following L-carnitine supplementation. During the study, no harmful effects were reported by patients. Conclusion: This is the novel study to determine the favorable effects of L-carnitine supplementation on lipid profiles in PV patients. However, further investigations are required to confirm these results.

Biography :

Elham Yaghubi has completed her MSc in Nutrition from School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Her field of interests is lifestyle/diet in the prevention of cardiovascular and inflammatory diseases, clinical/nutrition effects in relation to autoimmune diseases.

E-mail: sanaz.yaghobi93@gmail.com

 

Top
https://www.olimpbase.org/1937/